Iaterion, Inc.
PrivateLast Round
VC Round
Feb 14, 2024
Total Funding Raised
$298,883
Company Overview
Iaterion, Inc. operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was a VC Round in February 2024.
Iaterion, Inc. is a biotechnology company that develops targeted, selective nuclear receptor drugs as alternatives to menopausal hormone therapy for women's health and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iaterion, Inc. Comparables
Compare Iaterion, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sermonix Pharmaceuticals | 82% | |
| Azure Biotech, Inc. | 81% | |
| Atossa Therapeutics Inc | 74% |
For institutional investors. Book with your work email.
Iaterion, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 14, 2024 | ||||
| Grant | Sep 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Iaterion, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2024
Completed a VC Round funding round.
- Sep 1, 2023
$299K grant received from National Institute on Aging.
For institutional investors. Book with your work email.
Iaterion, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Iaterion, Inc.'s valuation, stock price, and market status.
Is Iaterion, Inc. a public or private company?
Iaterion, Inc. is a private company.
What is the current stock price of Iaterion, Inc.?
Iaterion, Inc. is a private company, so its shares have no public market price. Caplight tracks Iaterion, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Iaterion, Inc. worth (valuation)?
Valuation information for Iaterion, Inc. is not publicly available.
Can I buy Iaterion, Inc. stock?
Iaterion, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Iaterion, Inc.'s last funding round?
Iaterion, Inc.'s most recent funding round was VC Round on February 14, 2024.
Who are the main investors in Iaterion, Inc.?
Key investors in Iaterion, Inc. include National Institute on Aging.
Will Iaterion, Inc. IPO soon?
No public IPO plans have been announced for Iaterion, Inc..
How can I track Iaterion, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Iaterion, Inc.'s shares on secondary markets.